TSG101: A Novel Anti-HIV-1 Drug Target

E-ISSN： 1875-533x|17|8|750-758

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.8, 2010-03, pp. : 750-758

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing G-quartet oligonucleotides as novel anti-HIV agents: focus on anti-HIV drug design

By Jing N.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1777-1785

Informa Healthcare

Access to resources Recommend Favorite

Polyphenols: A Diverse Class of Multi-Target Anti-HIV-1 Agents

Current Drug Metabolism, Vol. 14, Iss. 4, 2013-05 ,pp. : 392-413

Bentham Science Publishers

Access to resources Recommend Favorite

Multivalent Agents: A Novel Concept and Preliminary Practice in Anti-HIV Drug Discovery

Current Medicinal Chemistry, Vol. 20, Iss. 6, 2013-02 ,pp. : 815-832

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Anti-HIV-1 Activity of a Novel Series of Aminoimidazole Analogs

Letters in Drug Design & Discovery, Vol. 7, Iss. 5, 2010-06 ,pp. : 318-323

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokine Receptor-directed Agents as Novel Anti-HIV-1 Therapies

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-06 ,pp. : 1017-1033

Bentham Science Publishers

Access to resources Recommend Favorite